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The polarity suppression (Psu) protein of bacteriophage P4 causes suppression of transcriptional polarity in Escherichia
coli by overcoming Rho termination factor activity. Two new psu mutants defective in polarity suppression are described.
The psu5 mutation deletes codons 95–98 from about the middle of the gene, and the mutant protein is inactive. The psu6
mutation changes Phe169 to Val and encodes a temperature-sensitive protein. Constitutive overexpression of psu/ from a
plasmid prevents colony formation, but overexpression of mutant genes (psu5, psu6) does not, suggesting that Psu disturbs
essential host function(s). Rho protein synthesis is enhanced several-fold in cells containing wild-type Psu, due to readthrough
at the rho attenuator, while the physical stability of Rho is maintained. As a consequence, Psu-producing cells accumulate
significantly more Rho than normal cells, reminiscent of termination-defective rho mutants. The polarity suppression activity
induced by Psu is demonstrated in vitro by the efficient readthrough of Rho-dependent terminators l tR1 and TIS2 during
coupled transcription –translation. Purified Rho protein restores termination at TIS2 when added to Psu-containing reactions
but NusG does not. The data support the hypothesis that Psu has or elicits an anti-Rho function. q 1997 Academic Press
INTRODUCTION information illuminating the molecular events that consti-
tute this mode of termination (for a complete review and
The efficiency of transcription termination by RNA poly- earlier references, see (Platt and Richardson, 1992; Platt,
merases is influenced by termination and antitermination 1994; Richardson, 1996). Rho is a homohexamer of 282
factors (reviewed in (Greenblatt et al., 1993; Richardson, kDa; each 47-kDa subunit has domains for RNA- and
1993)). The polarity suppression ( psu) gene product of ATP-binding. Rho binds to mRNAs that typically have little
Escherichia coli phage P4 is unique among these be- or no secondary structure and are usually G-poor and
cause it specifically antagonizes Rho factor-dependent C-rich, in the region⁄80 nt upstream of a Rho-dependent
termination (Linderoth and Calendar, 1991). In vivo, Psu terminator. Rho contacts RNA via an RPN1 motif located
interferes with this mode of termination in phage, plasmid in the amino-terminal third of the protein, and the binding
and bacterial transcription units, and its activity does not activates Rho ATPase. With the energy derived from nu-
depend on any specific terminator-proximal sequences cleotide hydrolysis, Rho translocates (5* to 3* ) in the
(Linderoth and Calendar, 1991). The molecular basis of direction of RNA polymerase, while probably remaining
Psu’s activity is not yet understood. The predicted amino bound to its initial RNA site. During the directed move-
acid sequence of Psu (21.3 kDa) has none of the de- ment, Rho can act as an RNA–DNA helicase. At a termi-
scribed RNA or DNA binding motifs, nor does psu resem- nation site, Rho catalyzes the dissociation of paused
ble other bacterial or phage genes (Dale et al., 1986; transcription complexes.
Linderoth and Calendar, 1991) except for one in the P4-
Physiological levels of the essential E. coli protein
related retronphage, fR73 (Sun et al., 1991). Although it
NusG (20 kDa) are also needed for Rho-dependent termi-
is not an essential gene, psu/ increases the burst size
nation in vivo. In cells depleted of NusG, terminationof P4 two- to fivefold (Sauer et al., 1981). A second activity
at most Rho-dependent terminators is greatly reducedof Psu, exterior capsid binding, appears to account for
(Sullivan and Gottesman, 1992), and the overproductionsome of this increase, which results from the improved
of NusG suppresses termination defects of certain rhostability of Psu-covered capsids (Isaksen et al., 1992).
mutants (Sullivan et al., 1992). However, excess NusGSince its discovery, Rho has been the paradigm tran-
can decrease Rho’s termination efficiency in wild-typescription termination factor (Roberts, 1969). Studies prob-
cells (Burova and Gottesman, 1995). Rho-dependent ter-ing Rho structure and function have yielded a wealth of
mination in vitro is also enhanced by NusG (Li et al.,
1993; Nehrke et al., 1993; Nehrke and Platt, 1994; Burns
and Richardson, 1995). In vitro, NusG binds to Rho (Li et1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (510) 643-5035; E-mail, rishard@uclink4.berkeley.edu. al., 1993) and to RNA polymerase (Li et al., 1992), and
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TABLE 1there is evidence for a quaternary complex composed of
RNA polymerase, RNA, NusG, and Rho (Nehrke and Platt, List of Plasmids
1994). NusG stimulates transcription elongation rates
Plasmid Description Source or referenceboth in vivo and in vitro, apparently by suppressing paus-
ing of RNA polymerase (Burova et al., 1995). Rho function
pGT8 l PR TIS2 phage P2 lysis region, ApR This workdepends strongly on the elongation rate of RNA polymer-
pGT51 Ptacpsu/, CmR, pACYC177 vector This workase (Jin et al., 1992). NusG is thought to enhance termina- pGT52 Ptac Dpsu, CmR, pACYC177 vector This work
tion by overcoming kinetic limits to Rho function at certain pGZ119EH lacIq, Ptac* CmR, ColD vector (Lessl et al., 1992)
pNL35 PR trp a lacZ, ApR (Linderoth andterminators (Burns and Richardson, 1995). Within the se-
Calendar, 1991)ries of events that constitute Rho-dependent termination,
pNL51 PR lacZ, ApR (Linderoth andthere are numerous stages where Psu could act to dis-
Calendar, 1991)
rupt Rho function. pNL65 PR ltR1 lacZ, ApR (Linderoth and
One objective of this work was to investigate whether Calendar, 1991)
pNL72 PR TIS2 lacZ, ApR (Linderoth andexpression of psu in vivo would lead to changes in Rho
Calendar, 1991)synthesis or stability that might account for the loss of
pNL150 Ptacpsu/, CmR, in pGZ119EH This workits activity. In this communication we show that polarity
pNL150-M5 Ptacpsu5, CmR, in pGZ119EH This worksuppression by Psu leads to elevated Rho synthesis, just pNL150-M6 Ptacpsu6, CmR, pGZ119EH This work
as occurs in termination-defective rho mutants. When pNL151 Ptac Dpsu, CmR, in pGZ119EH This work
assayed in vitro, crude extracts made from Psu-con-
taining cells have reduced Rho termination activity, but
the addition of Rho from wild-type cells to these extracts ing Xam95. For pGT8, a Bgl II–EcoRI fragment with ‘cro/
restores normal levels of termination. Psu has no observ- tR1 / TIS2 was removed from pGT6 and replaced with aable effect on Rho stability in vivo or in vitro. These find- BamHI–EcoRI fragment from pNL149, which has bases
ings support a model wherein Psu induces, directly or 1–873 of IS2 (Ghosal et al., 1979) cloned in pUC9 (Vieira
indirectly, the inactivation of Rho. We also present a pre- and Messing, 1982). This step supplied to pGT8 a transla-
liminary characterization of two new psu mutations iden- tion stop for the now 3* truncated cro gene and restored
tified using a simple genetic selection. TIS2 . Plasmids pNL150 and pNL151 were made for Lac
repressor-controlled, IPTG-inducible expression of psu/
MATERIALS AND METHODS and of a truncated Dpsu control gene. These contain
EcoRI–HindIII inserts from pNL3 and pNL6 (LinderothBacterial strains and plasmids
and Calendar, 1991), respectively, cloned after Ptac in theE. coli K-12 strain NAL008 (DlacX74 galU galK strA polylinker of pGZ119EH following its digestion with EcoRI
Dara-leu hsdR rna: :kan) was constructed by phage P1- and HindIII; pNL150-M5 and pNL150-M6 carry the corre-
mediated transduction (Miller, 1972) of MC1061 (Casada- sponding EcoRI–HindIII inserts bearing mutant psu
ban and Cohen, 1980) using a lysate grown on an genes from pGT51-M5 and pGT51-M6 (described in the
rna: :kan donor, DK533 (Srivastava et al., 1992); transduc- following section). To achieve lower expression of Ptactants were selected on LB plates (1% tryptone, 0.5% yeast psu/, a BstBI–XhoI segment from pNL150 bearing lacI q
extract, 0.5% NaCl, 1% agar) containing 25 mg kanamycin and Ptac psu
/ was blunt-end ligated to a HindIII– SmaI
per milliliter. Plasmids were propagated in DH5a (Gibco- vector fragment from pACYC177 (Chang and Cohen,
BRL). To maintain plasmids, 20 mg chloramphenicol (Cm) 1978), after both the fragments had been end-filled with
or 50 mg ampicillin (Ap) per milliliter were added to me- Klenow enzyme, resulting in pGT51; pGT52 has instead
dia, as required. the Dpsu allele from pNL151.
Plasmids discussed in the text are listed in Table 1;
construction of new plasmids is outlined below. Plasmid Isolation of new psu mutants
DNA for in vitro transcription–translation was purified by
cesium chloride-ethidium bromide gradients or on Qia- Mutants ( psu5, psu6) were isolated by a negative se-
lection, as follows. Cells (2 1 106) from replicate over-gen columns (Chatsworth, CA). pGT8 was constructed in
several steps, from pGT1 and pGT6. pGT1 was con- night cultures of strain C-1a (pGT8, pGT51) were spread
on LB plates containing Cm, Ap, and 0.1 mM isopropyl-b-structed from a NcoI (and Klenow end-filled)–PstI vector
fragment of pNL25 bearing l PR cro
/ tR1/ TIS2 (Linderoth, thiogalactopyranoside (IPTG). After overnight incubation,
medium or large colonies (one per replicate culture) were1990) and a SnaBI– PstI fragment containing the phage
P2 lysis region (extending from the 3* end of gene L to the restreaked twice on the same medium. In this selection,
expression of psu/ from pGT51 is induced by the IPTG;5* end of lysA: ‘L, X, Y, K, lysA ’) from pBBRV7 (Ziermann et
al., 1994). To make pGT6, a PstI–BstEII fragment with ‘L, Psu-mediated polarity suppression through TIS2 causes
the P2 lysis genes Y and K to be expressed from pGT8.X, Y, K ’ was excised from pGT1 and replaced with the
corresponding one from pRZ46 (from R. Ziermann) bear- (Gene X is not involved in lysis (Ziermann et al., 1994);
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the presence of Xam95 allele on pGT8 is irrelevant for the competitor protein was 3% BSA when using anti-Rho or
anti-NusG; when using anti-Psu or anti-PspA, it was SDS-work presented here.) Strains that survived the selection
carried candidate psu mutant plasmids and were desig- denatured total proteins of NAL008 (pGZ119EH) or K-
1472 (Linderoth et al., 1996), respectively. Precipitatesnated C-1a (pGT8, pGT51-Mn , where n  1 to 22). These
were screened for: (i) retention of K/ on pGT8 by plate were washed twice in 0.8 ml buffer I and once in RIPA
(10 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA,complementation of P2 Kam218 (Sunshine et al., 1971)
using the protocol described in Linderoth et al. (1991); 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS).
Proteins dissociated from beads by heating (1007, 5 min)(ii) survival of strains reconstituted from C-1a, pGT8, and
pGT51-Mn in broth cultures containing 1 mM IPTG; (iii) in sample buffer were separated by SDS–PAGE. Protein
mass standards were purchased from Amersham. Bandoverproduction of a Psu-sized protein by reconstituted
strains in broth cultures that were grown 2.5 hr with 1 mM intensities were quantified by phosphorimaging using a
Molecular Dynamics ImageQuant with software ver-IPTG (samples of overproducing cells were centrifuged,
dissolved in sample buffer by heating to 1007, and their sion 3.3.
Western blotting was performed as described pre-proteins were electrophoresed on sodium dodecyl
sulfate-containing polyacrylamide gels (SDS–PAGE) viously (Linderoth et al., 1996), except that SDS was omit-
ted from the transfer buffer. Blots were probed with anti-(Laemmli, 1970) and stained with Coomassie blue).
The EcoRI– HindIII regions of two candidate mutant sera (1:10,000 dilution) and developed by the enhanced
chemiluminescence procedure (Amersham).genes that satisfied the above criteria were subcloned
into pUC9 and sequenced in both directions using univer-
Preparation of S-30 extracts for coupledsal forward and reverse primers, a-[35S]dATP (Amer-
transcription–translationsham, Arlington Heights, IL), and T7 DNA polymerase
(Sequenase), reagents, and protocols from United States
S-30 extracts were prepared from NAL008 cells using
Biochemical (Cleveland, OH).
the procedure of Reynolds (1988); Psu activity in NAL008
is identical (not shown) to that measured in MC1061
Protein labeling and immunodetection (Linderoth and Calendar, 1991). NAL008 and its plasmid-
containing derivatives were grown in TB (1% tryptone, 5%
Methods used were those of Russel and Kazmierczak
NaCl, 1 mM MgSO4 , and 50 mM leucine) to OD A600 (1993) with modifications. For isotopic labeling of pro-
1.0–1.1, chilled 10 min (07), centrifuged (6,000 g, 15 min,
teins, cells were grown at 377 with aeration in minimal
47), rinsed once then resuspended in cold Buffer A (25
medium (Vogel and Bonner, 1956) supplemented with
mM K//HEPES, 1 mM EDTA (pH 7.6 at 47)) to OD A595 glucose, amino acids (except methionine), thiamine, bio-
300–350. The suspension was frozen in liquid N2 ,tin, and Cm to 4 1 108 cells/ml. Cells induced 5 min with
thawed (57), and after sequential additions of KCl (0.021
1 mM IPTG (unless indicated) were labeled 1 min with
volume of 4 M ), DTT (0.0021 volume of 2 M ) and egg-
[35S]methionine (per 0.1 ml cells, 20 mCi, 1000 Ci mmol01;
white lysozyme (0.011 volume of 25 mg/ml in Buffer A),
New England Nuclear, Wilmington, DE). In pulse-chase
incubated 20 min (07), frozen, and thawed a second time
experiments, excess unlabeled methionine (final 0.5 mg/
and centrifuged (45 min, 47, 35,000 RPM, Type 50Ti rotor).
ml) was added after 1 min. To obtain total denatured
Supernatants (S-30) were adjusted to 14 mM in Mg(OAc)2proteins, cells were treated with an equal volume of cold
and stored at 0707. Protein content was determined by
10% trichloroacetic acid (TCA); the precipitates were
the bicinchoninic acid method (Pierce, Rockford, IL) us-
rinsed with acetone, air-dried, and solubilized in 4% SDS
ing a bovine serum albumin (BSA) standard. In a trial
at 1007. To recover native proteins, labeled cells were
experiment consisting of overexpression of psu/, immu-
chilled on ice, washed in cold Tris-saline (50 mM Tris –
noprecipitation of [35S]methionine-labeled proteins with
HCl (pH 8.0), 100 mM NaCl), treated with 200 mM Tris –
anti-Psu serum, separation by SDS–PAGE and quantifi-
HCl (pH 8.0), 2 mM EDTA, 1 mM dithiothreitol (DTT), 20%
cation by phosphorimaging, ⁄95% of the total radioactiv-
sucrose, 100 mg/ml lysozyme, and 103 Kallikrein inhibitory
ity associated with the Psu band fractionated as a soluble
units aprotinin (Trayslol; Bayer) per milliliter for 30 min
extract protein (Fig. 1).
(47), frozen on dry ice, and thawed at 47 (twice), then
DNase (20 mg/ml) and MgCl2 (20 mM ) were added (30 Coupled transcription–translation assays
min, 47), and soluble proteins were separated from the
particulate fraction by centrifugation. Reaction conditions were modified from Zubay (1973)
and Reynolds (1988); reagents were purchased fromProteins from 107 cells were immunoprecipitated in
the presence of excess unlabeled competitor proteins at Sigma (St. Louis, MO). Reactions (25 ml) contained 10 ml
reagent cocktail (100 mM Tris–OAc (pH 7.9), ca. 20 mM47 in 0.5 ml buffer I (1% Triton X-100, 50 mM Tris–HCl
(pH 7.4), 150 mM NaCl, 5 mM EDTA) for 3 hr with anti- Mg(OAc)2 , 137 mM KOAc, 65 mM NH4OAc, 2.5 mM ATP,
3 mM each CTP, GTP, and UTP, 3.5 mM DTT, ca. 60sera (1:250 dilutions) and captured on StaphA sepharose
beads (Pharmacia, Piscataway, NJ). The nonspecific mM phosphoenol pyruvate, 550 mM each amino acid,
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ducing strain carrying pNL150 ( psu/), by treatment of
a cell lysate with polyethyleneimine followed by cation
exchange chromatography (N. Linderoth and R. Calen-
dar, unpublished procedure). Anti-sera were generously
supplied by the following individuals: anti-Rho, Dr. J. Rob-
erts (Cornell University, Ithaca, NY); anti-Psu, Dr. M. Isak-
sen (University of Oslo, Oslo, Norway); and anti-NusG,FIG. 1. Psu is a highly soluble cytoplasmic protein. NAL008 cells
carrying pNL150 ( psu/) or pNL151 (Dpsu) were grown in minimal me- Dr. J. Greenblatt (University Toronto, Toronto).
dium, induced 5 min with IPTG (1 mM ), labeled 1 min with [35S]-
methionine, and separated into soluble and particulate fractions by RESULTS
centrifugation. Samples from equal numbers of cells, as indicated
above the lanes, were precipitated with anti-Psu serum, and analyzed Isolation of new psu mutants
by SDS–PAGE (15% gel) and autoradiography. Symbols: psu/, NAL008
(pNL150 psu/); Dpsu, NAL008 (pNL151 Dpsu); T, total proteins; S, Two new psu mutations were isolated after they arose
soluble fraction; P, particulate fraction. Numbers indicate the percent- spontaneously during selection against low-level Psu ac-
age of total Psu in each fraction, determined by phosphorimaging. tivity. For the selection, psu/ was expressed in C-1a
(pGT51, pGT8) from pGT51, and Psu-mediated RT of the
IS2 terminator (TIS2) caused the lysis genes of phage P25% polyethylene glycol (PEG 6000–8000), 180 mM folinic
to be expressed from pGT8, and this killed the host (seeacid, 1.3 mM cAMP, 2 mM IPTG, 435 mg/ml tRNA, 9 u
Materials and Methods for details). One survivor carriedml01 pyruvate kinase), 10 ml combined S-30 extract (typi-
a mutation, psu5, which deletes 12 bases encodingcally 6–8 ml) and S-30 buffer (25 mM K//HEPES (pH 7.6),
amino acids 95–98 of Psu (nt 283–294). The deletion14 mM MgCl2 , 80 mM KCl, 2 mM DTT), 3 ml ddH2O, and
probably occurred by intramolecular recombination, be-2 ml supercoiled DNA template (1 mg, in 1 mM Tris–HCl
cause the missing bases comprise one-half of an 8-bp(pH 8.0)), and were incubated 1 hr (377) and halted by
direct repeat and a 4-bp spacer (the second repeat ex-chilling on ice. Each extract was optimized by determin-
tends from nt 295 to 302). Another survivor had psu6, aing the peak level of b-galactosidase activity produced
T to G transversion at position 505, which changedfrom control template pNL51 while varying the concentra-
Phe169 to Val. These mutations ( psu5, psu6) were intro-tions of Mg(OAc)2 and phosphoenol pyruvate. To assay
duced into an otherwise wild-type psu plasmid (pNL150)b-galactosidase, chilled reactions were centrifuged 2
by fragment exchange; others were mapped to regionsmin, and supernatant (20 ml) was incubated in Z-buffer
of the plasmid outside the psu gene and were not studied(1.0 ml) and orthonitrophenyl b-D-galactopyranoside, as
further. No host mutants were found among 22 candi-described before (Miller, 1972). After color development,
dates.0.5 ml 1 M Na2CO3 was added, samples were centrifuged
Even in the absence of the P2 lysis genes, colonies2 min, and the A420 of supernatants was determined.
failed to form on nutrient agar plates when Psu wasPicomoles orthonitrophenol (ONP) produced/min, was
made constitutively from plasmid pNL150 ( psu/) at inter-calculated as:
mediate (0.1 mM IPTG) or high (1 mM IPTG) levels (Table
(A420)(1.7 1 1003 liter) 4 (Dtmin)(20 1 1006 liter)(apM), 2). Remarkably, however, even high-level expression of
the deletion mutant psu5 did not interfere with growth.
where apM is the picomolar extinction coefficient of ONP Cells that synthesized Psu6 also could form colonies at 4.5 1 1009 pM01 cm01.
377 if plates contained up to 0.1 mM IPTG, although not
Readthrough (RT) of terminators on plasmids during
when higher levels were used (inclusion of 0.3 mM IPTG
transcription–translation was calculated by the method
resulted in a plating efficiency of 3 1 1002). However,
of Linderoth and Calendar (1991), following two or more
these same cells did form large colonies with only a
determinations. In control extracts, RT at ltR1 increased slightly reduced efficiency when grown with 1 mM IPTG
as extracts aged; therefore, to accurately assess the con-
at 427, and presumably high-level psu6 expression. In
tribution of Psu to RT, only fresh extracts (£3 days) were
contrast, cells making Psu/ exhibited the same low plat-
used. The efficiency of RT at TIS2 using Psu-containing ing efficiency on IPTG-containing plates at 427 as they
extracts was constant for6 months when extracts were
did at 377.
stored at 0707 and if thawed and refrozen once.
The stabilities of wild-type and mutant Psu proteins
were determined in pulse-chase experiments. After in-Purified proteins and anti-sera
duction at 427, the half-life of Psu6 was about 6 min,
which was significantly shorter than that measured forRho protein was a gift from Dr. D. Bear (University New
Mexico School of Medicine, Albuquerque). NusG was wild-type Psu (31 min; data not shown). This difference
can account for the temperature-sensitive functioning ofgiven by Drs. B. Stitt (Temple University, Philadelphia)
and J. Greenblatt (University of Toronto, Toronto). Psu the mutant Psu6 protein. However, after induction at 377,
both of the mutant proteins and wild-type Psu had similarwas purified to apparent homogenity from an overpro-
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TABLE 2 firmed that Rho synthesis was significantly (7-fold) higher
in Psu/ cells (lanes 1–4) than in control cells (lanes 5–Efficiency of Plating by Cells Expressing Wild-Type
8). The relative rates of Rho synthesis determined byand Mutant psu Genesa
phosphorimaging were (in arbitrary units): 90,820 {
IPTG 12,990 with Psu present (lanes 1–4), and 12,560 { 1,100
in its absence (lanes 5–8). Synthesis of Rho was elevated
Alleleb Temperature 0 0.1 mM 1 mM
slightly (1.4-fold; 17,870 { 840) even when psu/ was not
induced (Fig. 2B; lanes 9 and 10). This probably occurredDpsu 377 1.0 1.0 1.0
psu/ 377 1.0 8 1 1007 3 1 1007 because repression of Ptac is incomplete, allowing for a
427 1.0 6 1 1007 3 1 1007 small amount of Psu to be made. Comparable results
psu5 377 1.0 1.0 0.9 were obtained when the labeled proteins were immuno-
psu6 377 1.0 0.9 1.4 1 1006
precipitated from a native cytoplasmic extract rather than427 1.0 1.0 0.2
from a mixture of TCA-denatured proteins (not shown).None 377 2 1 1008 ND ND
Thus, one scenario, denaturation of Rho by Psu com-
a Replicate cultures grown in TB-Cm overnight at 377 without shaking, bined with a preferential recognition of denatured Rho
were diluted and spread on LB-Cm agar containing the indicated con- by the anti-serum, was ruled out. In contrast to these
centrations of IPTG. Colonies were counted after 16 hr at the stated
results, the nonfunctional mutant protein Psu5 did nottemperatures. Values are the average efficiency of plating from 5 inde-
enhance Rho synthesis rates at all (not shown).pendent testings, expressed relative to that measured without IPTG.
ND, not determined.
b psu was expressed in NAL008 from plasmids pNL150 (psu/), Intracellular Rho levels are increased by Psu
pNL151 (Dpsu), pNL150-M5 (psu5), or pNL150-M6 (psu6). None, plas-
mid-free NAL008. To determine if a parallel increase in the intracellular
concentration of Rho occurred in response to Psu, Rho
levels were compared by immunoblotting (Fig. 3). The
half-lives (35–40 min) and each was easily detected fol- amount of Rho in Dpsu control cells was the same irre-
lowing SDS–PAGE by staining with Coommassie blue spective of whether cells were induced 30 or 60 min with
(not shown). Psu5 and Psu6 accumulated to about one- 1 mM IPTG or were uninduced (lanes 2, 4, 9). The molar
half the level of the wild-type protein after 2.5 hr induction. amount of Rho they contained was similar to that re-
From this result we infer that growth inhibition by Psu is ported previously (Platt and Richardson, 1992), when the
attributable to its polarity suppression activity and not to approximate intracellular volume of the cells being ana-
a general stress on the host, such as a depletion of lyzed was considered. In contrast, cells that expressed
resources. psu/ contained 2-fold more Rho than control cells by 30
min after induction (lanes 5–7), and about 4-fold more
Psu alters Rho synthesis but not Rho stability
To investigate whether a reduction in Rho stability or
its synthesis could account for the growth inhibition and
termination defects caused by Psu, isotopic labeling and
immunoprecipitation with anti-Rho serum were used to
follow the fate of newly synthesized Rho. In a pulse-
chase experiment initiated 40 min after psu/ induction,
the stability of Rho protein made in the presence of Psu
(Fig. 2A, lanes 1–5) was equal to that made in its ab-
sence (lanes 6–10) and in uninduced cells (lanes 11 –
12). Virtually no loss of radioactivity from the Rho band FIG. 2. Rho synthesis is increased by Psu activity. Cultures of NAL008
occurred over the course of 1 hr, consistent with Rho carrying the indicated plasmids were grown to early log phase in mini-
mal medium and then induced with IPTG (1 mM ), or mock-induced,being a very stable protein (Ratner, 1976). Rho stability
and labeled 1 min with [35S]methionine. For the experiment shown inwas equally unaffected when psu/ was induced 5 min
(A), the labeling was followed with a chase of unlabeled methionine.prior to the pulse-chase (not shown). An unexpected find-
Labeled proteins were precipitated with TCA, solubilized in SDS, immu-
ing of both experiments was that greater quantities of noprecipitated with anti-Rho serum, and analyzed by SDS–PAGE (9%
Rho appeared to be made in the Psu-containing cells gel) and autoradiography. (A) Aliquots were removed for processing
immediately after the chase (0 min) or at the times (10, 20, 40, or 60(compare band intensities in Fig. 2A, lanes 1–5 versus
min) indicated above the lanes. Lanes: 1–5, induced pNL150 ( psu/);in lanes 6–10).
6–10, induced pNL151 (Dpsu); 11 and 12, uninduced pNL150 (psu/).To verify that Rho synthesis was indeed stimulated by
(B) Aliquots were processed immediately after the labeling period.
Psu, the relative rate of its production was determined Lanes: 1–4, replicates of induced pNL150 ( psu/); 5–8, replicates of
by pulse-labeling and immunoprecipitation. The results induced pNL151 (Dpsu); 9 and 10, replicates of mock-induced pNL150
(psu/).of several replicate experiments shown in Fig. 2B con-
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trol plasmids (pNL35, pNL51) appear in Table 1 and have
been described before (Linderoth and Calendar, 1991).
Following a period of transcription–translation, the inci-
dence of terminator RT was determined by analyzing
each reaction for its in vitro-synthesized b-galactosidase
activity.
We found that termination at Rho-dependent termina-
FIG. 3. Rho acumulates to higher levels in Psu-containing cells. tors ltR1 and TIS2 was greater than 95 and 99%, respec-
Cultures of NAL008 carrying pNL150 ( psu/) or pNL151 (Dpsu) were tively (Table 3), during transcription–translation with con-
grown to early log phase in TB-Cm and then induced with IPTG (1 mM )
trol extracts devoid of Psu (extracts I and II). Since termi-for 30 or 60 min, or mock-induced (0 min), as indicated above the lanes.
nation efficiencies equaled (at TIS2) or exceeded (at tR1)Cells were harvested on ice, pelleted, washed, and lysed in 4% SDS
values determined in vivo (Linderoth and Calendar, 1991),(1007). Samples from equal numbers of cells were mixed with SB and
the proteins were separated by SDS–PAGE (10% gel) and blotted to host-encoded termination factors must be present in suit-
nitrocellulose. The blot was probed with anti-Rho serum and developed able quantities in extracts prepared by this protocol, as
by enhanced chemiluminescence. Two replicate cultures of each strain
originally reported (Reynolds, 1988).were analyzed; similar results were obtained for both, and one is
In contrast, Psu-containing extracts (III, VI, VII) wereshown. Numbers above the lanes indicate relative amounts loaded per
markedly defective in Rho-dependent termination (Tablelane. Symbols: Dpsu, NAL008 (pNL151 Dpsu); psu/, NAL008 (pNL150
psu/); R, 25 ng Rho standard. 3), even though their synthetic capacity for transcription –
translation was the same as for control extracts I and II.
RT of tR1 was on average 10-fold higher in Psu-containing
after 60 min (lanes 9–12). About 1.5-fold more Rho was extracts than in control reactions, and RT of TIS2 was
made in uninduced psu/ cells (lanes 2 and 3). The polar- increased 60- to 70-fold. Two results confirmed that Psu
ity suppression activity of Psu was required for the in- synthesis in vivo was necessary for the termination defi-
creased Rho levels because no increase followed when ciency that we observed in vitro (Table 3). First, normal
cells expressed the mutant allele, psu5 (not shown). The levels of termination in vitro were seen with extract IV,
greater accumulation of Rho in Psu-containing cells is in made from cells containing pNL150 ( psu/) that were not
agreement with earlier studies (Ratner, 1976; Das et al., induced to make Psu. Second, extract V prepared after
1978; Richardson and Carey III, 1982) that reported sev- induction of the nonfunctional deletion plasmid pNL151
eral-fold overproduction of Rho in termination-defective (Dpsu), had no apparent termination defect.
rho mutants (see Discussion). The factor-dependency of terminators affected also
Additional pulse-labeling and immunoblotting experi-
ments showed that neither the synthesis nor accumula-
tion of NusG, nor that of a randomly chosen host protein
TABLE 3
(PspA), was stimulated by Psu (not shown).
Measurement of Terminator RT in Crude Extracts
Evidence for Psu-dependent polarity suppression
Percentage of RT at
using a crude extract system terminator (n)c
InductionTo initiate studies of Psu-mediated polarity suppres-
Extract Host plasmida (min)b ltR1 TIS2sion in vitro, an assay depending on coupled transcrip-
tion–translation in S-30 extracts (Zubay, 1973) was devel- I None 0 4.2 (4) 0.2 (2)
II None 0 0.7 (4) 0.5 (2)oped. The activity of in vitro-synthesized b-galactosidase,
III pNL150 (psu/) 30 36 (6) 29 (6)which is easily assayed and the product of lacZ, was
VI pNL150 (psu/) 45 10 (2) 34 (11)selected to indicate polarity suppression by Psu. Accord-
VII pNL150 (psu/) 60 16 (2) 29 (7)
ingly, control S-30 extracts were prepared from a strain IV pNL150 (psu/) 0 nd 0.3 (2)
(NAL008) lacking both endogenous b-galactosidase and V pNL151 (Dpsu) 60 nd 0.4 (2)
Psu, and Psu-containing extracts were made from the
a S-30 extracts were prepared from NAL008 carrying the indicatedsame host carrying pNL150 (psu/) following induction
plasmid.with IPTG. Very nearly all of the Psu synthesized was b Cells were induced with IPTG (1 mM) for the time stated prior to
soluble in S-30 extracts prepared by this method (see collection.
Fig.1 and Materials and Methods). In vitro-coupled tran- c Percentage terminator RT, the average ratio of ONP produced per
minute from the specified terminator plasmid, versus from terminator-scription–translation reactions with Psu-containing or
minus pNL51 assayed in parallel, 1 100% (number of repetitions), ascontrol extracts were primed with different template
described in Linderoth and Calendar (1991). Activities obtained usingDNAs, which consisted of ‘‘reporter’’ plasmids bearing
terminator-minus pNL51 (representing 100% RT) varied slightly for each
transcriptional signals (l PR promoter followed by a termi- extract and experiment, and were typically 1–3 1 106 nmol ONP min01.
nator) preceding lacZ. Reporter plasmids with Rho-de- Background activity (that obtained when no reporter plasmid was
added) resulted in RT values of 0.02–0.05%. nd, not determined.pendent terminators ltR1 (pNL65) or TIS2 (pNL72) and con-
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tion at TIS2 , and it did so in a concentration-dependent
manner, yielding essentially a linear response (Fig. 5A).
Nearly full termination at TIS2 was observed when 150
ng Rho was added (final 180 nM Rho or 30 nM hexamer).
In contrast, addition of purified NusG (3 mg/ml, 160 nM )
failed to restore termination or to stimulate RT in similar
experiments, and neither did BSA (to 6 mg/ml) (Fig. 5B).
These results highlight the specificity of Rho for reversing
the termination defect of Psu-containing S-30 extracts.
To rule out that Rho might be physically absent or less
abundant in the Psu-containing extracts versus in controlFIG. 4. Terminator RT in vitro is proportional to the fractional amount
of Psu-containing extract used in the reaction. RT of TIS2 was ascer- extracts, concentrations of Rho in each were compared
tained following transcription– translation reactions carried out with by SDS–PAGE followed by quantitative immunoblotting
mixed extracts, consisting of Psu/ extract III and control extract II (Table 4; Concentrations in S-30 extract). Eight concen-mixed in varying proportions, as indicated. Results are expressed as
tration standards of highly purified Rho were electropho-RT obtained with mixed extract relative to that obtained with the undi-
resed on these gels and blotted for comparison. Rholuted Psu-containing extract (1100%); average of 2 determinations.
content was found to be similar (within a twofold differ-
ence) in all preparations as well as in S-30 reactions
confirmed that RT in vitro depended on Psu. The Rho- (following additions of buffer, DNA, ddH2O, and reagent
independent terminator trp a (on pNL35) was equally cocktail), and thus its absence cannot be a cause of the
efficient (99% termination) in Psu-containing and control termination deficiency. In a separate experiment, Rho
extracts, just as was observed previously in vivo for psu- was not observed to degrade during incubation (377, 1
expressing and nonexpressing cells (Linderoth and Cal- hr) of complete reaction mixtures composed with Psu-
endar, 1991). Thus, both the terminator-specificity and containing extracts (not shown).
RT efficiency of Psu are faithfully reproduced in the S-30
termination assay.
Comparison of Psu and Rho content
Reversal of the termination defect by the
It is conceivable that Psu binds to Rho to cause the
addition of Rho
termination deficiency. We therefore determined if a suffi-
cient number of Psu molecules existed in termination-Additional tests were performed to characterize the
termination defect of the Psu-containing S-30s. Figure 4 deficient cells and extracts to bind all the Rho. To answer
this, molar concentrations of Psu and Rho in undilutedshows the levels of RT obtained using mixed extracts,
which consisted of Psu-containing extract combined with S-30 extracts and in unfractionated whole cell samples
were determined using quantitative immunoblotting (per-termination-proficient control extract. In different reac-
tions, the fraction of total extract that supplied Psu was formed as described above). The molar ratio of the two
proteins was then calculated based on these values (Ta-varied while other components were held constant, i.e.,
the extract was diluted with respect to Psu. The level of ble 4).
We found that Psu was present in considerable molarRT that resulted was clearly proportional to amount of
the Psu/ extract added (Fig. 4). For example, 80% of the excess (103-fold) over Rho in termination-deficient ex-
tracts III and VII (Table 4, lines 3 and 4, Concentrationsoriginal RT activity was obtained when 80% of the extract
was Psu/, and about 40% of the original RT activity was per S-30 extract). In contrast, only a modest (10-fold)
excess of Psu was found in samples of unfractionatedseen when 40% was Psu/, etc. Thus, the RT activity pre-
sumed to be due to Psu was limiting in reactions carried cells that had been induced for the same period of time
(lines 3 and 4, concentrations in whole cell samples).out with mixed extracts. Alternatively, the control extract
could be providing a factor that restored transcription An even lower Psu to Rho ratio (1.2) was measured for
uninduced psu/ cells (line 2). Even this low ratio supportstermination. The putative termination factor must be ab-
sent or have diminished activity in Psu-containing ex- a slightly elevated level of RT at the rho attenuator in
vivo (Figs. 2A, 2B, and 3). This means that polarity sup-tracts and be specific for Rho-dependent termination.
If the determining feature of Psu-containing extracts pression in vivo does not require the large excess of Psu
seen in vitro.is their deficiency of Rho termination activity, as could
be inferred from the results in Table 3 and Fig. 4, termina- Extracts and whole cell samples contained cellular
material from approximately 500 and 10 units (A600) pertion in vitro could possibly be restored to normal levels
just by adding Rho purified from wild-type cells. To test milliliter, respectively. Ideally, extracts should contain 50
times more Rho than whole cell samples and not roughlythis, parallel reactions with Psu-containing extract were
supplemented with increasing amounts of purified Rho. equivalent amounts as was seen. Note that Rho levels
in Psu-containing and control extracts are essentially theAddition of Rho was indeed sufficient to restore termina-
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FIG. 5. Specificity of Rho for restoring termination in Psu-containing extracts. RT of TIS2 was ascertained following transcription–translation
reactions with Psu-containing extract VI supplemented with additions, as shown (average of 2 determinations). (A) Reactions were done in the
presence of increasing amounts of purified Rho protein (circles) or the corresponding amount of Rho dilution buffer (squares). (B) Additions were
of the indicated reagents: NA, no addition; BSA, 150 ng; Rho, 150 ng (final 180 nM ); Rho buffer, buffer equivalent of added Rho; NusG, 75 ng (final
160 nM ); NusG buffer, buffer equivalent of added NusG.
same, but only the latter carries out Rho-dependent ter- DISCUSSION
mination efficiently (Table 3). In contrast, most all the Psu In this report, we have shown that the reduced Rho
originally present in cells was recovered in the extracts. termination activity observed for Psu-containing cells
Factors that could be responsible for differential recovery does not result from a reduced rate of Rho synthesis. On
of the two proteins are the gentle lysis procedure used, the contrary, these cells accumulate several times more
the unequal masses of the two proteins, and the extent Rho than their nonproducing counterparts. Moreover, ac-
to which each is complexed to other macromolecules celerated degradation cannot be causing Rho’s dysfunc-
inside cells. tion. The Rho made in Psu/ cells is stable, has the same
The Psu/Rho ratios given in Table 4 could be greater mobility during SDS–PAGE as that made in control cells,
by a factor of 3: the active form of Rho is a hexamer and does not degrade in vitro when Psu is present. Fi-
(Finger and Richardson, 1982), and the active form of Psu nally, in the context of a crude in vitro system, we could
is unknown but it could be a dimer (Dokland et al., 1993). restore Rho-dependent termination to Psu-containing ex-
In conclusion, the amount of Psu made is sufficient to tracts by adding Rho purified from wild-type cells. These
bind all the Rho, although we have yet to show that this findings clearly illuminate the termination defect of Psu-
hypothetical scenario describes the actual mechanism containing cells to be a loss of Rho activity, and not a
loss of Rho itself.leading to Rho inactivation (see Discussion).
TABLE 4
Concentrations and Ratio of Psu and Rho in S-30 Extracts and Cellsa
Concentrations in S-30 extracts Concentrations in whole cell samples
Psu/Rho Psu/Rho
Plasmidb Induction Rho (M)c Psu (M)c mol ratioc Rho (M)c Psu (M)c mol ratioc
None (II) None 180 nM NA NA 110 nM NA NA
psu/ (IV) None 310 nM 4.5 mM 14 160 nM 200 nM 1.2
psu/ (III) 30 min 230 nM 320 mM 1,390 320 nM 3.3 mM 10
psu/ (VII) 60 min 160 nM 310 mM 1,940 640 nM 7 mM 11
a Concentrations of Psu and Rho in undiluted S-30 extracts and in whole cell samples were assessed by quantitative immunoblotting, using for
comparison eight concentration standards of highly purified Psu or Rho. Undiluted S-30 extracts correspond to 530 to 640 units (A600) cell density
per milliliter. For whole cell samples, equal numbers of cells, grown and induced as described for the corresponding extract, were solubilized in
4% SDS (1007, 5 min) to final 10 units (A600) cell density per milliliter.
b Extracts (code used in Table 3) and cell samples were prepared from NAL008 carrying the indicated plasmid after induction with 1 mM IPTG
for the times shown.
c Molecular masses of 21.3 kDa for Psu and 47 kDa for Rho were used when calculating molar concentrations and ratios. The active form of
Rho is a hexamer (282 kDa (Finger and Richardson, 1982)). Psu is thought to be a dimer (Dokland et al., 1993). Thus, a ratio 0.33 indicates an
excess of Psu dimer over Rho hexamer. NA, not applicable.
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The overproduction of Rho by Psu is a logical outcome nitude and terminator specificity of RT, are qualitatively
reproduced.if one considers how rho is normally regulated. It is well-
Discriminating between the above hypotheses is a pri-established that rho expression is auto-regulated at the
ority that will require a detailed accounting of the specificmRNA level, by termination at the rho attenuator when
activity of Rho made in the presence and absence of Psu,Rho activity is high, and by readthrough (RT) when Rho
as well as purer components. A factor to be considered inactivity is low (Imai and Shigesada, 1978; Brown et al.,
the analysis is how well different terminators respond to1982; Tsurushita et al., 1984; Matsumoto et al., 1986). We
the level of Rho activity. RT of a strong terminator such ashave previously shown that Psu increases mRNA levels
TIS2 clearly requires a severe disturbance of Rho activity,distal to Rho-dependent terminators by transcriptional RT
because most rho mutations do not cause RT at this site(Linderoth and Calendar, 1991). Thus, the elevation of
(Das et al., 1976; Reyes et al., 1976). In contrast, en-Rho synthesis by Psu most likely results from a higher
hanced RT of the rho attenuator occurs even in rho mu-incidence of RT at the rho attenuator. Moreover, it is
tants with mild termination defects (Ratner, 1976; Imailikely that Psu could be altering the expression of other
and Shigesada, 1978; Richardson and Carey III, 1982),host genes, not identified here, that are normally regu-
and to some extent in uninduced cells containing pNL150lated by Rho.
(psu/) (Figs. 2A, 2B, and 3), which make just a little PsuRecently, Burova and Gottesman (1995) reported that
(Table 4). Therefore, reporter plasmids bearing the rhoinhibition of Rho activity due to overproduction of NusG
attenuator should also be used in future work.did not lead to elevated Rho levels. They postulated that
It is intriguing to consider an intimate Psu–Rho inter-regulation of termination at the rho attenuator might be
action as the cause of Rho’s inactivity. Mixed complexesqualitatively or quantitatively different from that occurring
of these proteins have not been detected using a fairlyat other Rho-dependent terminators (ltR1 , ltL1) (Burova
stringent technique (coimmune precipitation, not shown)and Gottesman, 1995). In vivo, the rho attenuator re-
but more sensitive biochemical and genetic screeningsponded to Psu just as other Rho-dependent terminators
methods should still be applied toward revealing theirdo (Linderoth and Calendar, 1991), suggesting a common
possible interaction (Phizicky and Fields, 1995). We havemeans for overriding termination controls through Psu.
shown here that Psu is made in sufficient quantities toHowever, a unique regulation of this terminator with re-
bind all the Rho made by cells. However, detecting evenspect to NusG could still explain the situation encoun-
a direct interaction that involves a minority of the Psu ortered by Burova and Gottesman (1995).
a minority of Rho molecules, for example only nascent
Somewhat surprisingly, the molar amounts of Rho Rho, is not trivial. If the latter were true, molecules of
needed to restore termination in vitro were far less than Rho made prior to psu induction would still be active,
of the extract’s endogenous Psu, which was determined which could account for the residual termination de-
to be in excess (Table 4). Moreover, RT activity was lim- tected in vitro. Last, since NusG deficiency has been
iting in a Psu-containing extract despite the abundance shown to correlate with reduced Rho activity (Sullivan
of Psu (Fig. 4). Several scenarios can explain our results. and Gottesman, 1992), if Psu does have Rho binding
First, it could be that only a portion of the Psu in the activity that is weak (direct) but sufficient to compromise
extract is active. Perhaps it is this portion that is able to termination at the rho attenuator, the elevated Rho:NusG
form productive complexes, possibly with an unknown ratio that would then result could indirectly reduce termi-
host factor(s), to cause the Rho inhibition. Presumably, nation at other sites. Conversely, Psu could act indirectly
it is productive complex formation, or these hypothetical by stimulating production of an unknown gene whose
host factors, that is limiting and not Psu per se. Alterna- product inactivates Rho.
tively, the intrinsic activity of Rho molecules made in the The two new psu mutations described here represent
presence of Psu may be nil or very low. In other words, only the second and third nonredundant mutations iso-
Psu might have carried out its function (inducing Rho lated in this gene that confer a polarity suppression-
inactivation) in vivo and have no further role in vitro. By minus phenotype, other than chain-terminating psu1
this scenario, Psu would not actually be causing polarity (Sauer et al., 1981; Isaksen et al., 1992); psu6 is the
suppression in vitro, but presumably it could if all neces- first temperature-sensitive mutation found. A missense
sary factors were present and conditions were right for mutation isolated previously, psu2 (identical to psu3;
the proposed Rho inactivation to occur. Third, cells and V45F) causes a defect in suppression of transcriptional
extracts could differ dramatically in their requirement for polarity, but the mutant protein still binds P4 capsids
Psu to block Rho activity, requiring modest amounts in (Isaksen et al., 1992). Recently, Psu molecules having
vivo but substantially more in vitro. In other words, the extra amino acids at the N-terminus were found to retain
appearance that Psu is limiting could be an artifact of both polarity suppression and capsid binding activity,
the unrefined extract system. However, even if the latter opening the way for P4 to be exploited as a peptide
was true, the S-30 termination assay is still a valuable display phage (Lindqvist and Naderi, 1995). More muta-
tions in psu need to be isolated and their effects charac-tool because important in vivo findings, such as the mag-
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Finger, L. R., and Richardson, J. P. (1982). Stabilization of the hexamericterized before residues responsible for polarity suppres-
form of Escherichia coli protein rho under ATP hydrolysis conditions.sion, capsid binding and stabilization, and growth inhibi-
J. Mol. Biol. 156, 203–219.
tion functions can be assigned with confidence. Ghosal, D., Sommer, H., and Saedler, H. (1979). Nucleotide sequence
However, based on data we obtained for psu5 and psu6, of the transposable element IS2. Nucleic Acids Res. 6, 1111–1122.
it is likely that regions of the protein needed for polarity Greenblatt, J., Nodwell, J. R., and Mason, S. W. (1993). Transcriptional
antitermination. Nature 364, 401–406.suppression will be the same as those involved in cell
Imai, M., and Shigesada, K. (1978). Studies on the altered Rho factorgrowth inhibition.
in nitA mutants of Escherichia coli defective in transcription termina-No host mutants resistant to Psu activity were isolated
tion. J. Mol. Biol. 120, 451–466.
using our direct screen. This is probably because Psu Isaksen, M. L., Rishovd, S. T., Calendar, R., and Lindqvist, B. H. (1992).
severely inhibits Rho function and rho is an essential E. The polarity suppression factor of bacteriophage P4 is also a decora-
tion protein of the P4 capsid. Virology 188, 831–839.coli gene (Das et al., 1976). A genetic screening based
Jin, D. J., Burgess, R. R., Richardson, J. P., and Gross, C. A. (1992). Termi-on conditional lethality could prove useful to identify can-
nation efficiency at rho-dependent terminators depends on kineticdidate host gene products that Psu interacts with to elicit
coupling between RNA polymerase and rho. Proc. Natl. Acad. Sci.the loss of Rho activity. USA 89, 1453–1457.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assem-
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